Supplemental material
Open access
12,318
Views
9
CrossRef citations to date
0
Altmetric
Original Research
Effect of oral semaglutide on the pharmacokinetics of thyroxine after dosing of levothyroxine and the influence of co-administered tablets on the pharmacokinetics of oral semaglutide in healthy subjects: an open-label, one-sequence crossover, single-center, multiple-dose, two-part trial
Camilla Haugea Clinical Pharmacology, Novo Nordisk A/S, Søborg, DenmarkCorrespondence[email protected]
View further author information
, View further author information
Astrid Breitschaftb Klinikum Westend, PAREXEL International GmbH, Berlin, GermanyView further author information
, Marie-Louise Hartoft-Nielsenc Medical and Scientific, Novo Nordisk A/S, Søborg, DenmarkView further author information
, Simon Jensend Biostatistics, Novo Nordisk A/S, Søborg, DenmarkView further author information
& Tine A. Bækdala Clinical Pharmacology, Novo Nordisk A/S, Søborg, DenmarkView further author information
Pages 1139-1148
|
Received 08 Apr 2021, Accepted 12 Jul 2021, Published online: 31 Aug 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.